case_id,genetic_tests,realistic_all_3,text,run1_realistic,run2_realistic,run3_realistic
Case884,WES,False,"A 32-week gestation fetus was referred by a developmental pediatrician for prenatal whole exome sequencing (WES) after fetal imaging raised concern for possible postnatal neurologic abnormality, with features described as concerning for a movement disorder such as dystonia, ataxia, hemiplegia or another neuromuscular process, and prior karyotype testing was nondiagnostic; there is a family history of multiple congenital anomalies in the mother, the parents declined pre-test genetic counseling, and testing is being pursued with coverage through UHC.",True,False,False
Case10315,WES,False,"NO
The case is unrealistic because a neonatologist would not be the appropriate provider managing a 2-year-old child.",False,False,False
Case14017,WES,True,"An otherwise healthy 7-week-old infant is being evaluated by the general pediatrician for a high-risk brief resolved unexplained event (BRUE) with recurrent witnessed seizure-like events, and whole exome sequencing (WES) has been ordered to evaluate for a possible genetic etiology. Prior karyotype testing was nondiagnostic. There is a family history of neurologic disease, specifically a maternal uncle reported to have a movement disorder with dystonia and ataxia, and pre-test genetic counseling was completed with plans for post-test follow-up. Testing is being pursued with coverage through BCBS_FEP.",True,True,True
Case6756,WES,False,"The 68-year-old patient was referred by cardiology for whole exome sequencing (WES) to evaluate a lifelong history of choanal atresia and to investigate a potential genetic etiology for this congenital nasal airway anomaly. Prior karyotype testing was nondiagnostic, the patient reports a sister with ovarian carcinoma, pre-test genetic counseling has been completed with plans for post-test follow-up, and testing is being pursued with coverage through Cigna.",False,False,True
Case1778,WES,True,"The patient is a 14-year-old adolescent referred by the primary care physician for genetic evaluation of an ocular coloboma, and whole exome sequencing (WES) has been requested for diagnostic clarification; prior fluorescence in situ hybridization testing was nondiagnostic.",True,True,True
Case4604,WES,True,"The patient is a six-year-old child referred by the primary care physician for evaluation of developmental delay and intellectual disability without a specific syndromic diagnosis suspected; prior chromosomal microarray (CMA) testing was nondiagnostic, and the family reports an older sibling with moderate to severe intellectual disability diagnosed by age 18; whole exome sequencing (WES) is being requested to evaluate for an underlying genetic cause, pre-test counseling has been completed with a genetic counselor with plans for post-test follow-up, and the family has coverage through BCBS_FEP.",True,True,True
Case3422,WES,True,"The patient is a 34-year-old referred by oncology for evaluation of congenital choanal atresia and consideration of whole-exome sequencing (WES) to assess for an underlying genetic etiology after a nondiagnostic chromosomal microarray (CMA); the patient has Cigna coverage, has seen a genetic counselor multiple times, and reports a mother who was diagnosed with breast cancer at age 50.",True,True,True
Case5212,WES,False,"At 22 weeks' gestation the pregnancy is being evaluated for suspected choanal atresia identified on prenatal imaging, and a neurologist has ordered whole exome sequencing (WES) to assess for an underlying genetic etiology; fragile X testing was previously performed and was nondiagnostic, there is a family history in the father of a movement disorder characterized by dystonia and ataxia, coverage is through UHC, and pre-test genetic counseling has been completed with plans for post-test follow-up.",True,False,False
Case10917,WES,True,"The patient is an 8-week-old infant evaluated by a medical geneticist for persistent conjugated hyperbilirubinemia not attributed to total parenteral nutrition-associated cholestasis, and whole exome sequencing (WES) has been ordered to evaluate for an underlying genetic cause; family history is notable for an older sibling with multiple congenital anomalies, and Fragile X testing was previously performed and was nondiagnostic; pre-test counseling was completed with a genetic specialist and the family has coverage through UHC.",True,True,True
Case18821,WES,True,"The obstetrician requests fetal whole exome sequencing (WES) at 22 weeks' gestation after prenatal imaging identified findings concerning for multiple congenital anomalies affecting different organ systems, and the test is intended to evaluate a possible genetic etiology to inform perinatal counseling and management. Family history is notable for a maternal aunt reported to have dysmorphic features. There is no prior genetic testing and no documentation of pre-test genetic counseling, and the patient has coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",True,True,True
Case13,WES,True,"The newborn is being evaluated by the general pediatrician for multiple congenital anomalies that do not fit a well-delineated genetic syndrome and has been referred for whole exome sequencing (WES) after karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, pre-test genetic counseling was completed and post-test follow-up is planned, and testing will be submitted with coverage through BCBS_FEP.",True,True,True
Case8621,WES,True,"A 2-year-old child with a complex neurodevelopmental disorder with autism is undergoing evaluation with whole exome sequencing (WES) to seek a unifying diagnosis after prior chromosomal microarray (CMA) testing was nondiagnostic; the test was ordered by the child’s oncologist and is planned with coverage through UHC, the family reports an uncle with a congenital anomaly as relevant family history, and the family has met with a genetic counselor multiple times with pre-test counseling completed and plans for post-test follow-up.",True,True,True
Case8051,WES,True,"An infant of 5 weeks with a major congenital cardiac anomaly is being evaluated with whole exome sequencing (WES) ordered by the family medicine physician, and prior fluorescence in situ hybridization testing was nondiagnostic; the history is notable for a mother with short stature raising concern for a growth-related genetic condition, the family completed pre-test genetic counseling and will follow up after results, and testing is being pursued to clarify the etiology of the cardiac defect and potential syndromic associations with billing through BCBS_FEP.",True,True,True
Case13517,WES,True,"The 16-year-old patient was referred by a developmental pediatrician for evaluation of conjugated hyperbilirubinemia not attributable to total parenteral nutrition–associated cholestasis, and whole exome sequencing (WES) was ordered to evaluate for an underlying genetic cause given a sibling with laboratory abnormalities suggestive of an inborn error of metabolism. Fragile X testing was previously performed and was nondiagnostic. Pre-test counseling was completed with a genetic counselor and post-test counseling is planned, and testing will be billed through UHC.",True,True,True
Case4458,WES,False,"A newborn is being referred by the oncology service for whole exome sequencing (WES) because of concern for a complex neurodevelopmental disorder with early features that raise concern for autism spectrum disorder, and prior evaluation included a nondiagnostic chromosomal microarray (CMA); there is a family history notable for a sibling with laboratory abnormalities suggestive of an inborn error of metabolism, pre-test genetic counseling has been completed with plans for post-test follow-up, and testing will be pursued with coverage through UHC.",True,False,False
Case3359,WES,True,"The patient is a 4-year-old child referred by a developmental pediatrician for evaluation of significant hypotonia and ongoing developmental concerns; chromosomal microarray (CMA) testing was previously performed and was nondiagnostic, and there is a family history notable for a sibling with developmental delay. Whole exome sequencing (WES) is being requested to evaluate for an underlying genetic etiology, pre-test counseling has been completed with a genetic counselor on multiple occasions, and plans for post-test follow-up and care coordination are in place with coverage through UHC.",True,True,True
Case6726,WES,False,"NO
A neonatologist would not be the appropriate provider for a 12-year-old, as neonatology care is limited to newborns so this age–provider combination is unrealistic.",False,False,False
Case2496,WES,True,"A prenatal evaluation at 32 weeks' gestation has been requested by a neonatologist for whole exome sequencing (WES) with coverage through UHC because of parental consanguinity and concern for autosomal recessive conditions, there is a reported family history of sudden unexplained death in a sibling before age 35, prior fluorescence in situ hybridization testing was nondiagnostic, and no genetic counseling has been completed, so WES is being pursued to assess risk for potential postnatal outcomes based on fetal imaging and to guide perinatal planning.",True,True,True
Case8485,WES,True,"An 8-year-old child with hypotonia first noted in infancy is being evaluated by the general pediatrician for persistent motor delay and evolving tone abnormalities, and whole exome sequencing (WES) has been ordered to investigate a possible genetic etiology; prior Fragile X testing was nondiagnostic, the family reports a sibling with autism spectrum disorder, pre-test genetic counseling was not performed, and testing will be submitted with coverage through Cigna.",True,True,True
Case5674,WES,True,"A 9-year-old child with persistent seizures is being evaluated by a general practitioner and has had multiple visits with a genetic counselor; a prior chromosomal microarray (CMA) was nondiagnostic, and the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome given a family history notable for sudden unexplained death in an uncle before age 35, with testing requested under BCBS_FEP and arrangements for post-test follow-up with genetics.",True,True,True
Case8975,WES,False,"NO
This is not realistic because prenatal/fetal cases cannot use neurodevelopmental outcome labels such as ""global developmental delay,"" so the indication is invalid for a 15-week gestation specimen.",False,False,False
Case1552,WES,False,"NO
Prenatal cases cannot list neurodevelopmental or movement disorder terms such as dystonia or ataxia, so fetal testing for these indications is not allowed.",False,False,False
Case7507,WES,False,"NO
The scenario is unrealistic because a neonatologist would not be the ordering provider for a 10-year-old child.",False,False,False
Case12158,WES,True,"The infant is a 6-week-old presenting with multiple congenital anomalies not specific to a well-delineated genetic syndrome and whole exome sequencing (WES) has been ordered by the obstetrician for diagnostic evaluation; prior Fragile X testing was nondiagnostic. There is a family history of a sibling who had a brief resolved unexplained event with altered level of responsiveness, cyanosis and irregular breathing. No genetic counseling has been conducted to date and testing will be pursued with coverage through Cigna with coordination planned with pediatrics and genetics for post-test follow-up.",True,True,True
Case3494,WES,True,"The six-week-old infant was referred by the general pediatrician for genetic evaluation because of a congenital abnormality affecting at least one organ system with concern for an evolving complex neurodevelopmental disorder; no prior genetic testing has been performed, and there is a family history of dysmorphic features in a sibling, so whole exome sequencing (WES) is being requested for diagnostic clarification, genetic counseling was declined by the family, and coverage is through Cigna.",True,True,True
Case7297,WES,True,"This 3-year-old child was referred by a family medicine physician for evaluation of multiple congenital anomalies affecting different organ systems; prior karyotype testing was nondiagnostic and whole exome sequencing (WES) is being pursued to identify an underlying genetic etiology, the family reports a maternal aunt with ovarian cancer which raises concern for a possible familial predisposition, pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and the family has coverage through UHC and consents to WES to guide diagnosis, management, and cascade testing if indicated.",True,True,True
Case9978,WES,True,"The 53-year-old patient is undergoing whole exome sequencing (WES) at the request of the neurologist to evaluate an epileptic encephalopathy that began before age three and has persisted into adulthood; Fragile X testing was previously performed and was nondiagnostic. The patient has a brother with an inborn error of metabolism, has coverage through UHC, and completed pre-test counseling with a genetic counselor with plans for post-test follow-up.",True,True,True
Case9157,WES,False,"NO
This case is unrealistic because a neonatologist would not typically manage or order testing for a 4-year-old child, as neonatology care is limited to the neonatal period.",False,False,False
Case4196,WES,True,"The patient is a 10-year-old referred by a cardiologist for evaluation of apparent nonsyndromic developmental delay and intellectual disability, and whole exome sequencing (WES) is being requested as the next diagnostic step; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, and there is a family history of a brother who was diagnosed with moderate to severe intellectual disability in childhood, pre-test genetic counseling has been completed with plans for post-test follow-up, and coverage is through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",True,True,True
Case10711,WES,False,"NO
BRUE (brief resolved unexplained unexplained event) is an infant-specific diagnosis and is not a plausible clinical indication for a 48-year-old patient.",False,False,False
Case5626,WES,False,"A 15-year-old male with metastatic prostate cancer is being evaluated by his general pediatrician and referred for germline whole exome sequencing (WES) to assess for an underlying hereditary cancer predisposition given a maternal history of breast cancer diagnosed at age 50 or younger, there is no prior genetic testing documented and no mention of pre-test genetic counseling, and testing will be pursued with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",True,False,True
Case5569,WES,False,"A six-year-old child was referred by neurology for evaluation of a high-risk brief resolved unexplained event with recurrent witnessed seizure-like events and is being considered for whole exome sequencing (WES) to assess for an underlying genetic etiology, with no prior genetic testing documented; the family history is notable for two maternal aunts on the same side of the family who had cancers associated with Lynch syndrome, no pre-test genetic counseling has been completed, and testing will be submitted with coverage through BCBS_FEP with plans for post-test result review and neurologic follow-up.",True,True,False
Case14141,WES,True,"The patient is a 7-year-old referred by an oncologist for evaluation of multiple congenital anomalies and whole exome sequencing (WES) is planned to investigate an underlying genetic etiology, with prior chromosomal microarray (CMA) testing reported as nondiagnostic; there is a family history of global developmental delay in a sibling, coverage is through the Blue Cross Blue Shield Federal Employee Program (FEP), and pre-test genetic counseling has been completed with arrangements for post-test counseling and follow-up.",True,True,True
Case13282,WES,False,"NO
The clinical indication refers to invasive prenatal testing but the patient is an 8-year-old rather than a fetus, so prenatal phrasing is inconsistent with the provided age.",False,False,False
Case18882,WES,True,"An 8-year-old child is referred by a developmental pediatrician for evaluation of multiple congenital anomalies affecting several organ systems, and whole exome sequencing (WES) is being requested with coverage through UHC; prior fluorescent in situ hybridization (FISH) testing was nondiagnostic, the family reports that the mother has long QT syndrome, and the family declined pre-test genetic counseling but agreed to proceed with testing with plans to coordinate post-test counseling to review results and management.",True,True,True
Case1519,WES,False,"NO
""Brief Resolved Unexplained Event"" (BRUE) is an infant-specific diagnosis and is not compatible with a 13-year-old patient.",False,False,False
Case5230,WES,True,"The 15-year-old adolescent was referred by neurology for whole exome sequencing (WES) to evaluate a congenital anomaly after a nondiagnostic chromosomal microarray (CMA). There is a family history of an inborn error of metabolism in a sibling, the patient has coverage through UHC, and genetic counseling was declined at this time.",True,True,True
Case11124,WES,True,"An infant is presenting for evaluation of developmental delay and whole-exome sequencing (WES) has been ordered with coverage through UHC, following referral by an oncologist; pre-test counseling was completed and post-test genetic counseling is planned after results are returned. Prior fluorescence in situ hybridization testing was nondiagnostic. The family history is notable for an older sibling who had significant hearing impairment diagnosed in childhood, which raises concern for a hereditary etiology and supports comprehensive exomic testing.",True,True,True
Case8288,WES,True,"Fetal imaging at 36 weeks' gestation is concerning for a major congenital cardiac anomaly and the pregnancy was referred by a developmental pediatrician for genetic evaluation. A chromosomal microarray (CMA) was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism affecting an older sibling, and the parents have had multiple sessions with a genetic counselor. Given the late-gestation identification of a significant cardiac malformation and the nondiagnostic CMA, whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology that could inform perinatal and postnatal management, with coverage through UHC noted.",True,True,True
Case7376,WES,True,"The patient is a 73-year-old referred by a neurologist for evaluation of a major abnormality involving at least one organ system that remains unexplained, and whole exome sequencing (WES) has been ordered for diagnostic clarification. Prior fluorescent in situ hybridization testing was nondiagnostic. The patient reports that a sister had triple negative breast cancer, which raises concern for an underlying heritable predisposition. Pre-test counseling was completed with a genetic specialist and testing will proceed with coverage through UHC.",True,True,True
Case7682,WES,True,"This 9-year-old child was referred by a developmental pediatrician for evaluation of multiple congenital abnormalities affecting different organ systems and whole exome sequencing (WES) is being requested to identify a potential genetic cause; prior karyotype testing was nondiagnostic, there is a family history of developmental delay in a sibling, and pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and the family has coverage through UHC.",True,True,True
Case17377,WES,True,"The patient is a 7-week-old infant referred by the obstetrician for evaluation of a congenital anomaly and has been requested to undergo whole exome sequencing (WES); prior karyotype testing was nondiagnostic. There is a family history notable for a maternal uncle with dystonia and ataxia and other neurologic abnormalities, raising concern for an inherited movement or neuromuscular disorder. Pre-test counseling has been completed and the family will return for post-test genetic counseling after results are available, and testing will be submitted with coverage through BCBS_FEP.",True,True,True
Case19302,WES,False,"NO
This scenario is unrealistic because a neonatologist would not be the managing provider for a 7-year-old child.",False,False,False
Case16603,WES,False,"An 8-week-old infant was referred by a nurse practitioner for whole exome sequencing (WES) to evaluate for an underlying genetic etiology that could confer risk for moderate to profound intellectual disability later in development, prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, there is a family history of long QT syndrome in a maternal uncle, pre-test genetic counseling has been completed with plans for post-test follow-up, and testing will be pursued with coverage through UHC.",False,True,True
Case19905,WES,True,"The patient is a 3-year-old referred by the developmental pediatrician for evaluation of multiple congenital anomalies and is being considered for whole exome sequencing (WES) with coverage through UHC; prior karyotype testing was nondiagnostic, there is a family history notable for a mother with long QT syndrome, and no genetic counseling has been conducted to date.",True,True,True
Case1006,WES,False,"NO
A neonatologist would not be the appropriate ordering provider for a 13-year-old patient because neonatology is limited to newborn care.",False,False,False
Case2847,WES,True,"A 5-week-old infant was referred by cardiology after a high-risk brief resolved unexplained event that required cardiopulmonary resuscitation, and whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology; prior chromosomal microarray (CMA) testing was nondiagnostic. There is a family history of the mother having a persistent and severe immunologic or hematologic disorder, and the family has coverage through BCBS FEP. Pre-test counseling was completed with a genetic counselor and plans are in place for post-test follow-up.",True,True,True
Case16681,WES,False,"NO
A neonatologist would not be the appropriate ordering provider for a 3-year-old child because neonatologists care for newborns, making the age–provider pairing unrealistic.",False,False,False
Case10529,WES,True,"The child is a 6-year-old with apparent nonsyndromic developmental delay and intellectual disability who was referred by neurology for genetic evaluation; Fragile X testing was previously performed and was nondiagnostic, and there is a family history of neurologic disease in a maternal uncle with dystonia and ataxia. The family has seen a genetic counselor multiple times and pre-test counseling is complete with plans for post-test follow-up, and whole exome sequencing (WES) is being pursued with coverage through UHC.",True,True,True
Case18167,WES,False,"NO
A 58-year-old being managed by a developmental pediatrician is unrealistic because pediatric subspecialists do not provide ongoing care for adult patients.",False,False,False
Case16487,WES,True,"The newborn is being evaluated for a high-risk brief resolved unexplained event (BRUE) characterized by recurrent events in the absence of respiratory infection, and whole exome sequencing (WES) has been ordered by the oncologist following nondiagnostic fluorescence in situ hybridization (FISH) testing, the family history is notable for a maternal aunt with a persistent severe immunologic or hematologic disorder, the infant has coverage through UHC, and pre-test counseling was completed with plans for post-test genetic follow-up.",True,True,True
Case14744,WES,False,"NO
An adult patient age 55 being managed by a developmental pediatrician is unrealistic.",False,False,False
Case811,WES,True,"The patient is a 7-week-old infant referred by the general pediatrician for evaluation of early-onset movement abnormalities characterized by dystonia, ataxia and intermittent hemiplegic episodes concerning for a neuromuscular or movement disorder, and chromosomal microarray (CMA) was previously performed and reported as nondiagnostic; given the clinical presentation and a positive family history in an older sibling with multiple congenital anomalies, whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology, pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing is being ordered with coverage through BCBS_FEP.",True,True,True
Case9408,WES,True,"The 17-year-old patient is undergoing whole exome sequencing (WES) at the request of a medical geneticist for evaluation of epileptic encephalopathy with onset before three years of age; chromosomal microarray (CMA) testing was previously performed and was nondiagnostic. There is a family history of a persistent and severe immunologic or hematologic disorder in the patient's mother, and pre-test counseling was completed with plans for post-test follow-up with a genetic counselor. Testing will be submitted to Blue Cross Blue Shield Federal Employee Program (FEP) for coverage.",True,True,True
Case16458,WES,False,"NO
A 3-year-old being managed by a neonatologist is unrealistic because neonatologists care for neonates and this age–provider pairing is not permitted.",False,False,False
Case4067,WES,True,"The 5-year-old was referred by a developmental pediatrician for evaluation of significant hypotonia and whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology; prior chromosomal karyotype testing was nondiagnostic, and there is a family history of sudden unexplained death in a paternal uncle before age 35 that raises concern for a heritable disorder, with the family reporting coverage through UHC.",True,True,True
Case4982,WES,True,"An 11-year-old with a history of Hirschsprung disease was referred by a developmental pediatrician for genetic evaluation and is being considered for whole exome sequencing (WES) to evaluate for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, and the patient has a sibling who developed epileptic encephalopathy before age three, raising concern for a heritable syndromic or neurodevelopmental condition; the family has coverage through UHC and has met with a genetic counselor multiple times for pre-test counseling with plans for post-test result disclosure and multidisciplinary follow-up.",True,True,True
Case8710,WES,True,"The patient is a 12-year-old who was referred by a developmental pediatrician for genetic evaluation of autism spectrum disorder with at least one additional abnormality affecting another organ system, and whole exome sequencing (WES) has been requested to investigate an underlying genetic etiology. Prior karyotype testing was nondiagnostic. There is a reported family history of neurologic disease in a paternal uncle characterized by dystonia and ataxia. No pre-test genetic counseling was documented and the family plans to proceed with testing with coverage through UHC.",True,True,True
Case13613,WES,True,"At 22 weeks' gestation fetal imaging identified multiple structural anomalies and the pregnancy was referred by neurology for evaluation with whole exome sequencing (WES) to assess potential genetic etiologies that could inform postnatal management and counseling. Fragile X testing was previously performed and was nondiagnostic. There is a family history of dysmorphic features in a maternal aunt, and pre-test discussion occurred with a genetic specialist and testing will be pursued with coverage through UHC.",True,True,True
Case1501,WES,True,"The patient is a 2-year-old child referred by a developmental pediatrician for evaluation of multiple congenital anomalies and ongoing developmental concerns, and prior karyotype testing was nondiagnostic; there is a family history of Long QT syndrome in the mother. Whole exome sequencing (WES) is being ordered to identify an underlying genetic etiology, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through UHC.",True,True,True
Case10451,WES,True,"The patient is a 10-year-old with moderate to severe intellectual disability diagnosed in childhood who was referred by neurology for whole exome sequencing (WES) to evaluate an unexplained neurodevelopmental disorder; prior chromosomal microarray (CMA) testing was nondiagnostic. There is a family history of a sibling who had a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing. The neurologist placed the order, there is no documentation of prior genetic counseling, and testing will be pursued with coverage through UHC.",True,True,True
Case3255,WES,False,"NO
Prenatal cases cannot include neurodevelopmental or behavioral diagnoses such as autism spectrum disorder in the clinical history or family history.",False,False,False
Case4627,WES,False,"NO
This case is unrealistic because a neonatologist would not be managing a six-year-old child.",False,False,False
Case2150,WES,False,"NO
A neonatologist managing a 17-year-old adolescent is inconsistent with the age–provider rules, making this scenario unrealistic.",False,False,False
Case4262,WES,True,"The five-week-old infant presents with multiple congenital anomalies that do not fit a well-delineated genetic syndrome and was referred by the patient's oncologist for diagnostic whole exome sequencing (WES); prior karyotype testing was nondiagnostic, and family history is notable for a sibling who experienced a brief resolved unexplained event with altered responsiveness, cyanosis, pallor, and irregular breathing, pre-test genetic counseling has been completed and post-test follow-up with genetics is planned, and testing will proceed with coverage through BCBS_FEP.",True,True,True
Case19321,WES,True,"The patient is a 1-year-old referred by a neurologist for evaluation of a complex neurodevelopmental disorder with features concerning for autism spectrum disorder, and whole exome sequencing (WES) is being pursued to investigate a possible genetic etiology; prior chromosomal microarray (CMA) testing was nondiagnostic. A maternal aunt is reported to have multiple congenital anomalies, pre-test genetic counseling was completed, and plans are in place for post-test follow-up, with coverage through UHC.",True,True,True
Case11795,WES,True,"The patient is a three-week-old infant referred by a cardiologist for evaluation of a high-risk brief resolved unexplained event (BRUE) with a markedly abnormal electrocardiogram concerning for channelopathy, significant arrhythmia, cardiomyopathy, myocarditis, or structural heart disease. Chromosomal microarray (CMA) was previously performed and was nondiagnostic, so whole exome sequencing (WES) is being ordered to evaluate for an underlying genetic cause. There is a family history of a sibling with moderate to severe intellectual disability diagnosed in childhood, pre-test genetic counseling has been completed with plans for post-test follow-up, and testing will be billed through BCBS_FEP.",True,True,True
Case9349,WES,True,"The patient is a 5-year-old with a congenital cardiac anomaly affecting a single organ system who was referred by a cardiologist for genetic evaluation and whole exome sequencing (WES) because the family history raises concern for an inherited etiology, specifically a paternal uncle who experienced sudden unexplained death before age 35; prior fluorescence in situ hybridization testing was nondiagnostic, pre-test counseling was completed with a genetic counselor and plans for post-test follow-up are confirmed, and testing will be pursued with coverage through BCBS_FEP.",True,True,True
Case5130,WES,True,"Fetal tissue from a pregnancy loss at 32 weeks gestation is being submitted by a general pediatrician for evaluation with whole-exome sequencing (WES) to assess for a possible genetic etiology of the fetal demise, with the mother insured through UHC; there is a reported family history of a sibling who had laboratory abnormalities suggestive of an inborn error of metabolism, prior fragile X testing was nondiagnostic, and there is no documented pre-test genetic counseling or other prior testing information.",True,True,True
Case14127,WES,True,"Seventeen-year-old referred to medical genetics for evaluation of global developmental delay (GDD) with lifelong cognitive and adaptive deficits, and whole exome sequencing (WES) is being pursued to investigate an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic. There is a family history of epileptic encephalopathy in a sibling with onset before three years of age. The medical geneticist is coordinating testing, the patient saw a genetic counselor for pre-test counseling and will return for post-test counseling, and the testing will be submitted with coverage through UHC.",True,True,True
Case950,WES,True,"The 38-year-old patient is being evaluated by a medical geneticist for unexplained epileptic encephalopathy with onset before three years of age and has not had prior epilepsy multigene panel testing, so whole exome sequencing (WES) is being pursued to look for an underlying genetic cause; karyotype testing was previously performed and was nondiagnostic. The family history is notable for an uncle with metastatic, high-risk prostate cancer with intraductal/cribriform histology. The patient has seen a genetic counselor multiple times, has coverage through UHC, and plans are in place for post-test counseling and follow-up.",True,True,True
Case15834,WES,True,"The infant is being evaluated for concern for autism spectrum disorder based on early signs and was referred by the primary care physician for genetic assessment; whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology, and prior Fragile X testing was nondiagnostic. There is a family history of a maternal aunt with a congenital anomaly. Pre-test counseling was completed with a genetic specialist and testing will be pursued with coverage through UHC.",True,True,True
Case10333,WES,False,"The pregnancy is at 25 weeks' gestation and was referred by the obstetrician after prenatal imaging identified a major congenital cardiac anomaly, so whole-exome sequencing (WES) is requested to evaluate for an underlying genetic etiology and to guide perinatal counseling and management; prior fluorescent in situ hybridization testing was nondiagnostic, and there is a family history of a sibling who had notable hypotonia or hypertonia in infancy, information that prompted discussion with a genetic specialist during pre-test counseling and plans for post-test follow-up with the prenatal genetics team, with coverage through Cigna.",False,False,True
Case14371,WES,True,"An 11-year-old with complex neurodevelopmental disorder and autism spectrum disorder is being evaluated by the general pediatrician who has ordered whole exome sequencing (WES) to investigate an underlying genetic etiology; prior Fragile X testing was nondiagnostic, and there is a family history of a maternal aunt with a persistent severe immunologic disorder, which may inform interpretation of results, and the family met with a genetic counselor before testing with plans for post-test follow-up, with coverage through UHC.",True,True,True
Case604,WES,False,"NO
Autism spectrum disorder cannot be reliably diagnosed in a newborn (age 0 years), so ordering whole exome sequencing for ASD at this age is clinically unrealistic.",False,False,False
Case10458,WES,False,"NO
The label ""multiple congenital anomalies"" is a pediatric-only indication and is not an appropriate current diagnostic indication for a 38-year-old adult.",False,False,False
Case1130,WES,True,"The 68-year-old patient was referred by cardiology for evaluation of persistent seizures and is undergoing whole exome sequencing (WES) to assess for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, and the patient reports a sister with ovarian, fallopian tube, or peritoneal carcinoma in the family, which was reviewed during counseling. The patient has seen a genetic counselor multiple times with plans for post-test follow-up and testing is being arranged with coverage through UHC.",True,True,True
Case11514,WES,True,"The 10-year-old patient is being evaluated for conjugated hyperbilirubinemia not attributable to total parenteral nutrition and whole exome sequencing (WES) has been requested to investigate a potential genetic cause of cholestatic liver disease; a chromosomal microarray (CMA) was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism in a cousin, which raises concern for an inherited metabolic disorder contributing to the hepatic phenotype. The test was ordered by the patient's oncologist, coverage is through UHC, and there is no documentation of pre-test genetic counseling.",True,True,True
Case2147,WES,False,"The patient is a 7-week-old infant referred by the neonatologist for whole exome sequencing (WES) to evaluate for an underlying genetic condition that could be associated with moderate to profound intellectual disability later in development; Fragile X testing was previously performed and was nondiagnostic, there is a family history of global developmental delay in a maternal uncle, the family declined pre-test genetic counseling, and testing will be pursued with coverage through UHC.",True,True,False
Case503,WES,True,"The 2-year-old child was referred by a nurse practitioner for whole exome sequencing (WES) to evaluate a high-risk brief resolved unexplained event (BRUE) with recurrent witnessed seizure-like events; prior chromosomal microarray (CMA) testing was nondiagnostic, the parents report consanguinity, and pre-test genetic counseling has been completed with plans for post-test follow-up with the genetics team, with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",True,True,True
Case13675,WGS,True,"The patient is an 8-week-old infant referred by a neonatologist for evaluation of significant congenital hearing and/or visual impairment identified in early infancy, and whole genome sequencing (WGS) is being pursued for diagnostic clarification; prior fluorescence in situ hybridization testing was nondiagnostic. The family history is notable for a father with long QT syndrome, which will be considered in interpretation of any cardiac-associated findings. There is no documentation of pre-test genetic counseling and testing is being requested with coverage through UHC with planned post-test follow-up by the neonatal team.",True,True,True
Case15359,WGS,False,"NO
Autism cannot be diagnosed in a 6-week-old infant because neurodevelopmental disorders are not reliably identifiable at that age.",False,False,False
Case3474,WGS,True,"The patient is a 5-year-old who was evaluated by a medical geneticist for congenital choanal atresia and whole genome sequencing (WGS) is being ordered to assess for an underlying genetic etiology or syndromic association given the structural airway anomaly and a reported older sibling with developmental delay, prior karyotype testing was nondiagnostic, pre-test genetic counseling has been completed on multiple occasions with plans for post-test follow-up, and testing is being pursued with coverage through UHC.",True,True,True
Case13983,WGS,True,"The patient is a 7-week-old infant being evaluated for a high-risk brief resolved unexplained event (BRUE) with a significantly abnormal electrocardiogram (ECG) that raises concern for an underlying channelopathy, arrhythmia, cardiomyopathy, myocarditis, or structural heart disease, and whole genome sequencing (WGS) is being pursued at the request of the ordering gynecologist given the concerning cardiac findings and family history. Prior fluorescent in situ hybridization testing was nondiagnostic. The maternal uncle has a history of unexplained developmental regression reported as unrelated to autism or epilepsy and this family history prompted consideration of an inherited etiology. Pre-test counseling was completed with a genetic counselor and plans are in place for post-test follow-up, and testing will be billed through BCBS_FEP.",True,True,True
Case11981,WGS,True,"The patient is a 9-year-old child referred by neurology for evaluation of a history of abnormal muscle tone noted in infancy that has persisted with ongoing motor concerns and developmental surveillance; fragile X testing was previously performed and was nondiagnostic. Whole genome sequencing (WGS) is being requested to evaluate for an underlying genetic etiology after pre-test discussion with a genetic specialist, and the family reports coverage through UHC. Family history is notable for a maternal uncle with a persistent severe immunologic disorder, which has been considered in the differential and counseling.",True,True,True
Case10427,WGS,True,"An 8-week-old infant was referred by a neurologist for evaluation of significant hypotonia, and whole genome sequencing (WGS) is being requested to identify a potential genetic etiology; fluorescence in situ hybridization (FISH) testing was previously performed and was nondiagnostic. The family history is notable for an older sibling who experienced unexplained developmental regression not related to autism or epilepsy. Pre-test counseling has been completed with a genetic counselor on multiple occasions and post-test follow-up is planned, and testing is being ordered with coverage through UHC.",True,True,True
Case18528,WGS,False,"NO
A 10-year-old being managed by a neonatologist is unrealistic because neonatologists provide care for neonates and are not the appropriate provider for a child or adolescent.",False,False,False
Case17822,WGS,True,"The patient is a 13-year-old referred to medical genetics for evaluation of multiple congenital anomalies affecting different organ systems, and whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test after a nondiagnostic chromosomal microarray (CMA). The family history is notable for a sibling with short stature, genetic counseling was declined prior to testing, and the order was placed by a medical geneticist with coverage through UHC, with plans to review results and coordinate further evaluation and management as indicated.",True,True,True
Case6747,WGS,True,"A 12-year-old child with multiple congenital anomalies is undergoing whole genome sequencing (WGS) ordered by the medical geneticist to evaluate a suspected genetic etiology. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic. The family reports a sibling with developmental delay, pre-test counseling has been completed and post-test counseling is planned, and the patient has coverage through BCBS_FEP.",True,True,True
Case15938,WGS,True,"The patient is a one-week-old infant under the care of a neonatologist being evaluated for conjugated hyperbilirubinemia not related to total parenteral nutrition and whole-genome sequencing (WGS) is being considered to identify a potential genetic cholestatic or metabolic etiology; prior karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, no pretest genetic counseling is documented, and the family has coverage through UHC.",True,True,True
Case17037,WGS,False,"NO
An 11-year-old being managed by a neonatologist is unrealistic because neonatologists care for newborns and not for children/adolescents.",False,False,False
Case1799,WGS,False,"NO
A neonatologist ordering genetic testing for a 3-year-old is unrealistic because neonatologists manage newborns rather than children beyond the neonatal period.",False,False,False
Case18868,WGS,True,"The patient is a 41-year-old with a diagnosis of primary peritoneal carcinoma who was evaluated by a medical geneticist and for whom whole genome sequencing (WGS) has been ordered to assess for an underlying hereditary cancer predisposition; prior karyotype testing was nondiagnostic. Her mother reportedly has a persistent and severe hematologic disorder, which raised concern for a heritable syndrome affecting cancer and hematologic risk. Coverage is through Cigna, and there was no documented record of pre-test genetic counseling in the materials provided.",True,True,True
Case2162,WGS,True,"An infant aged 7 weeks was referred by a general practitioner for whole genome sequencing (WGS) to evaluate multiple congenital anomalies affecting multiple organ systems identified at birth; prior Fragile X testing was nondiagnostic, the family history is notable for an older sibling with autism spectrum disorder, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through BCBS_FEP.",True,True,True
Case7447,WGS,True,"At 33 weeks' gestation, fetal imaging raises concern for an isolated severe congenital heart defect and the cardiologist has ordered whole genome sequencing (WGS) to evaluate for a possible genetic etiology and to guide postnatal management; prior fragile X testing was nondiagnostic, family history is notable for a maternal aunt with triple-negative breast cancer, there is no documentation of pre-test genetic counseling, and coverage is through BCBS_FEP.",True,True,True
Case1104,WGS,False,"The 2-week-old infant was referred by a neurologist for whole genome sequencing (WGS) to evaluate concerns for a complex neurodevelopmental disorder, including possible autism spectrum disorder; prior chromosomal microarray (CMA) testing was nondiagnostic.",False,False,True
Case5380,WGS,True,"An 8-week-old infant is referred by neurology for evaluation of high-risk brief resolved unexplained events (BRUE) with recurrent witnessed seizure-like episodes, and whole genome sequencing (WGS) is requested to assess for an underlying genetic cause; prior chromosomal microarray (CMA) testing was nondiagnostic, and there is a maternal history of short stature as a growth abnormality, the family declined pre-test genetic counseling, and testing will be pursued with coverage through UHC.",True,True,True
Case2469,WGS,False,"NO
A neonatologist ordering genetic testing for a 3-year-old is unrealistic because neonatologists care for neonates and infants rather than children beyond infancy.",False,False,False
Case16294,WGS,False,"NO
Global developmental delay is a pediatric neurodevelopmental diagnosis and is not a plausible current indication for genetic testing in a 72-year-old adult.",False,False,False
Case3465,WGS,True,"The patient is a 2-year-old being evaluated by a medical geneticist for developmental delay and intellectual disability without a specific syndrome suspected, and whole genome sequencing (WGS) has been ordered to search for an underlying genetic etiology with coverage through UHC, prior Fragile X testing was nondiagnostic, and there is a family history of Long QT syndrome in the patient's father; pre-test counseling was completed with a genetic counselor and plans are in place for post-test counseling and result review.",True,True,True
Case16282,WGS,False,"The infant is a one-week-old referred by a neurologist for genetic evaluation because of concerns for early intellectual disability, and whole genome sequencing (WGS) is being requested to assess for an underlying genetic etiology; the family history is notable for an affected brother with short stature and failure to thrive, fluorescence in situ hybridization testing was previously performed and was nondiagnostic, and the family has completed pre-test counseling with a genetic counselor on multiple occasions with plans for post-test follow-up, with coverage through UHC.",True,False,True
Case14174,WGS,False,"The patient is a 7-week-old infant referred by the neonatologist for evaluation because of early behavioral concerns suggestive of autism spectrum disorder and for assessment of a possible inborn error of metabolism given an older brother with laboratory abnormalities concerning for a metabolic disorder, and whole genome sequencing (WGS) has been ordered to investigate genetic etiologies; Fragile X testing was previously performed and was nondiagnostic, the family reports coverage through UHC, and pre-test genetic counseling was completed with plans for post-test follow-up.",True,False,False
Case5885,WGS,True,"An 11-year-old patient was referred by neurology for evaluation of a major abnormality affecting at least one organ system and whole genome sequencing (WGS) is requested to investigate an underlying genetic cause, Fragile X testing was previously performed and was nondiagnostic, and there is a family history of long QT syndrome in the mother; pre-test counseling was discussed with a genetic specialist and plans for post-test follow-up are in place with coverage through UHC.",True,True,True
Case19162,WGS,True,"The infant is a neonate presenting with complex neurologic abnormalities including dystonia, ataxia, and asymmetric weakness suggestive of neonatal hemiplegia and was referred by a medical geneticist for whole genome sequencing (WGS) to evaluate for an underlying genetic or metabolic cause. Fragile X testing was previously performed and was nondiagnostic, and there is a family history of an inborn error of metabolism in a sibling. Pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing will be pursued with coverage through BCBS_FEP.",True,True,True
Case7604,WGS,True,The neonate was referred by a neurologist for evaluation of multiple congenital anomalies affecting several organ systems and whole genome sequencing (WGS) has been ordered to evaluate for an underlying genetic etiology. Fluorescence in situ hybridization (FISH) testing was performed previously and was nondiagnostic. There is a family history notable for an older sibling with multiple congenital anomalies. The family has coverage through UHC and they declined genetic counseling at this time.,True,True,True
Case8661,WGS,True,The patient is a 7-year-old referred by the child's neurologist for evaluation of a significant hearing or visual impairment identified in childhood and whole genome sequencing (WGS) is requested to investigate a possible genetic cause. Fragile X testing was previously performed and was nondiagnostic. There is a family history of a sibling who developed an epileptic encephalopathy before three years of age. Genetic counseling was offered but the family declined pre-test counseling; testing is being pursued with coverage through UHC and plans are in place to provide post-test genetic counseling and genetics follow-up if results are informative.,True,True,True
Case16514,WGS,False,"NO
A neonatologist would not appropriately be the ordering provider for a 2-year-old child, so this scenario is unrealistic.",False,False,False
Case10850,WGS,True,"The patient is a 13-year-old with global developmental delay being evaluated by a developmental pediatrician and whole genome sequencing (WGS) has been ordered to search for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, there is a family history of an aunt with dysmorphic features, and the family completed pre-test genetic counseling with plans for post-test follow-up, with testing pursued through UHC coverage.",True,True,True
Case13406,WGS,True,"The infant is 6 weeks of age and is being evaluated for concern of global developmental delay, with a family history notable for a sibling who experienced a brief resolved unexplained event described as altered level of responsiveness with cyanosis, pallor, and irregular breathing; chromosomal microarray (CMA) was previously performed and was nondiagnostic. Whole genome sequencing (WGS) has been ordered by a medical geneticist to assess for an underlying genetic etiology, pre-test counseling has been completed, and the family will follow up with the genetic counselor after results, with testing submitted for coverage through UHC.",True,True,True
Case577,WGS,False,"NO
A 5-year-old child being managed by a neonatologist is unrealistic because neonatologists provide care for neonates rather than older children.",False,False,False
Case7014,WGS,True,"An infant aged seven weeks was referred by neurology for evaluation of multiple congenital anomalies that do not fit a well-delineated genetic syndrome, and whole genome sequencing (WGS) is being requested to identify an underlying genetic etiology. Prior karyotype testing was nondiagnostic. There is a family history of a maternal aunt with a congenital anomaly. Pre-test genetic counseling was completed with a genetic specialist and results will be reviewed with the family and the neurology team, with coverage through UHC.",True,True,True
Case6451,WGS,True,"The 7-week-old infant was evaluated by a developmental pediatrician for significant hypotonia and whole genome sequencing (WGS) is being pursued to identify a potential genetic cause. The family reports that the mother has a history of a persistent, severe immunologic or hematologic disorder. A prior karyotype was nondiagnostic. Pre-test counseling has been completed and post-test follow-up with genetics is planned, and testing is being obtained with coverage through UHC.",True,True,True
Case18281,WGS,True,"The patient is a 6-year-old child referred by the cardiologist for evaluation of multiple congenital anomalies that do not fit a well-delineated genetic syndrome, and the cardiologist has ordered whole genome sequencing (WGS) to assess for an underlying genetic etiology. Fragile X testing was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism in a sibling. No genetic counseling was conducted prior to testing and the family has coverage through UHC.",True,True,True
Case10363,WGS,True,The patient is a 7-year-old child with a congenital anomaly present since birth who was referred by the general practitioner for whole genome sequencing (WGS) after fluorescence in situ hybridization (FISH) testing was nondiagnostic. The family history is notable for a maternal aunt with pancreatic cancer and the family has coverage through UHC. The patient has been seen multiple times by a genetic counselor for pre-test counseling and plans for post-test follow-up are in place. WGS is being pursued to provide a comprehensive genomic evaluation given the longstanding congenital findings and prior nondiagnostic targeted testing.,True,True,True
Case15557,WGS,True,"A 15-year-old referred by neurology for evaluation of a congenital anomaly present since birth is being evaluated with whole genome sequencing (WGS) to identify an underlying genetic etiology, and prior fluorescent in situ hybridization (FISH) testing was nondiagnostic; the patient has a sibling with a similar congenital anomaly and has been seen by a genetic counselor multiple times with plans for post-test counseling and coordination of care, and testing is being pursued with coverage through UHC.",True,True,True
Case4512,WGS,True,"The patient is a 21-year-old referred by the primary care physician for evaluation of a major congenital cardiac anomaly present since birth, and whole genome sequencing (WGS) is being pursued to identify a potential genetic etiology; there is a family history of a sibling who experienced a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing which raised concern for a heritable predisposition, and no prior genetic testing has been performed, pre-test counseling was completed with a genetic counselor and a post-test visit is planned with testing submitted with coverage through BCBS_FEP.",True,True,True
Case1428,WGS,True,"The three-week-old infant is being evaluated by a medical geneticist for Hirschsprung disease and whole genome sequencing (WGS) has been ordered to assess for an underlying genetic cause given a family history of an older sibling with severe intellectual disability diagnosed by age 18. Fragile X testing was previously performed and was nondiagnostic, and there is no documented pre-test genetic counseling. Testing will be submitted through UHC for coverage.",True,True,True
Case17265,WGS,False,"A 7-week-old infant is being evaluated by the general pediatrician for concerns about a complex neurodevelopmental disorder with early behavioral and motor features raising concern for autism spectrum disorder, and whole genome sequencing (WGS) is being requested to evaluate for an underlying genetic etiology; chromosomal microarray (CMA) was performed previously and was nondiagnostic, and there is a family history of a congenital anomaly in a maternal aunt, pre-test genetic counseling has been completed with plans for post-test follow-up and testing is being arranged with coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",False,False,True
Case5605,WGS,True,"The patient is an 11-year-old being evaluated for a major congenital cardiac anomaly and was referred by an obstetrician for whole genome sequencing (WGS) to assess for an underlying genetic cause. A prior chromosomal microarray (CMA) was nondiagnostic, pre-test counseling was completed with a genetic specialist, and insurance coverage is through BCBS_FEP. Family history is notable for a maternal aunt with pancreatic cancer.",True,True,True
Case14155,WGS,True,"The child is a 7-year-old referred by neurology for evaluation of autism spectrum disorder and whole genome sequencing (WGS) has been requested to assess for genetic contributors to the neurodevelopmental presentation. There is a family history notable for a maternal uncle with a persistent, severe immunologic disorder, which raised concern for an inherited predisposition that might overlap with neurodevelopmental features. There has been no prior genetic testing, and pre-test genetic counseling was declined by the family; testing is being pursued with coverage through Cigna.",True,True,True
Case9208,BRCA1/2,False,"NO
The indication references a fetal structural anomaly yet the patient is documented as a 34-year-old adult, so prenatal testing language is not appropriate.",False,False,False
Case3223,BRCA1/2,True,"The 75-year-old woman was referred by her general practitioner for BRCA1 and BRCA2 testing because her sister had epithelial ovarian cancer, and she has a history of a major congenital cardiac anomaly for which a chromosomal microarray (CMA) was previously performed and reported as nondiagnostic. There is no documentation of pre-test genetic counseling, and she has coverage through BCBS_FEP.",True,True,True
Case16944,BRCA1/2,False,"NO
Autism spectrum disorder cannot be reliably diagnosed in a 6-week-old infant, making the stated clinical indication temporally impossible.",False,False,False
Case14195,BRCA1/2,True,"An 18-year-old with a history of a major congenital cardiac anomaly is being evaluated by an oncologist and referred for BRCA1/2 testing because of a family history that includes a maternal uncle with dystonia and ataxia, prior karyotype testing was nondiagnostic, no pretest genetic counseling has been conducted, and the patient has coverage through BCBS_FEP.",True,True,True
Case22,BRCA1/2,True,"An 18-year-old man is undergoing BRCA1/2 testing to evaluate for a possible hereditary predisposition in the setting of high-risk prostate cancer with intraductal/cribriform histology and metastatic disease, with testing ordered by his neurologist; his father also had metastatic high-risk prostate cancer with intraductal/cribriform features. A prior chromosomal microarray (CMA) was nondiagnostic. He completed pre-test counseling and will return for post-test follow-up with a genetic counselor, and the testing is being pursued with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",True,True,True
Case2963,BRCA1/2,False,"NO
This is unrealistic because BRCA1/2 hereditary cancer testing is being requested in the context of primarily neurologic and pediatric neurodevelopmental features, including a family history of infantile hypotonia, which is a contextual inconsistency.",False,False,False
Case19255,BRCA1/2,True,"The patient is a 38-year-old woman with a history of two separate primary breast cancers who was referred by her neurologist for BRCA1/2 testing to evaluate for hereditary breast and ovarian cancer predisposition, she reports a family history notable for a father with metastatic prostate cancer, prior fluorescence in situ hybridization testing was nondiagnostic, and pre-test counseling was completed with a genetic specialist with testing to be pursued with coverage through UHC.",True,True,True
Case15458,BRCA1/2,True,"The patient is a 19-year-old woman with a personal history of breast cancer who is being evaluated for BRCA1 and BRCA2 testing because of a family history that includes ovarian cancer in a maternal aunt and a close relative with metastatic or intraductal/cribriform prostate cancer, prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, the testing was ordered by a nurse practitioner, and the patient completed pre-test genetic counseling with plans for post-test follow-up, with coverage through BCBS_FEP.",True,True,True
Case10644,BRCA1/2,False,"NO
Ordering BRCA1/2 testing for a 3-year-old evaluated for developmental delay is unrealistic because adult hereditary cancer testing should not be performed in the context of a pediatric neurodevelopmental evaluation.",False,False,False
Case6867,BRCA1/2,True,"She is a 50-year-old woman with a personal history of breast cancer who presents for BRCA1 and BRCA2 testing because she reports a brother with metastatic prostate cancer demonstrating intraductal features and a mother who was diagnosed with breast cancer at age 50; she has no prior genetic testing documentation. She was referred by a nurse practitioner and has had multiple pre-test counseling visits with a genetic counselor, and the planned BRCA1/2 testing will be pursued with coverage through BCBS_FEP.",True,True,True
Case16126,BRCA1/2,True,"The patient is a 6-week-old infant being evaluated for multiple congenital anomalies and BRCA1 and BRCA2 testing has been ordered by a gynecologist. FISH testing was previously performed and was nondiagnostic, the parents are reported to be consanguineous, pre-test counseling has been completed with plans for post-test follow-up with a genetic counselor, and testing will be billed through BCBS_FEP.",True,True,True
Case15642,BRCA1/2,False,"NO
The scenario is unrealistic because the patient is a 64-year-old adult with a pediatric-only indication of a brief resolved unexplained event being managed by a pediatric neurologist, which is not appropriate for an adult.",False,False,False
Case2211,BRCA1/2,True,"A 21-year-old patient is referred by a general practitioner for BRCA1 and BRCA2 (breast cancer susceptibility) testing because of a personal history of a primary solid tumor and reports of at least two additional affected blood relatives on the same side of the family; the patient states that the mother carries a known BRCA2 pathogenic variant. No prior genetic testing has been performed, and pre-test counseling was completed with a genetic specialist with plans for post-test follow-up. Testing is being requested through UHC to clarify hereditary cancer risk and to guide management for this young adult.",True,True,True
Case3529,BRCA1/2,False,"NO
This is unrealistic because ""multiple congenital anomalies"" is a pediatric-only indication and cannot be a current testing indication for a 53-year-old adult.",False,False,False
Case14408,BRCA1/2,True,"The patient is a 75-year-old who was referred by a family medicine physician for BRCA1/2 testing because of dysmorphic features and a family history notable for a brother with breast cancer; there is no prior genetic testing, pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, and testing will be billed through Cigna.",True,True,True
Case9527,BRCA1/2,False,"NO
This scenario is unrealistic because a 55-year-old adult is being managed by a developmental pediatrician, which violates age–provider constraints.",False,False,False
Case15644,BRCA1/2,False,"NO
This case is unrealistic because a neonatologist would not be the managing or ordering provider for a 22-year-old adult.",False,False,False
Case11877,BRCA1/2,False,"NO
Ordering BRCA1/2 testing for a 5-year-old evaluated for autism spectrum disorder is unrealistic because BRCA1/2 are adult-onset cancer susceptibility genes and mixing a pediatric neurodevelopmental indication with adult hereditary cancer testing is a contextual inconsistency.",False,False,False
Case4056,BRCA1/2,False,"NO
This case is unrealistic because a 57-year-old adult being managed by a general pediatrician is not appropriate under the age–provider rules.",False,False,False
Case7992,BRCA1/2,True,"The newborn was referred by a neurologist for evaluation of parental consanguinity and potential hereditary cancer risk because the mother has had two different primary solid tumors. Prior karyotype testing was nondiagnostic. The family declined pre-test genetic counseling, BRCA1 and BRCA2 testing was requested, and the patient has coverage through Cigna.",True,True,True
Case5981,BRCA1/2,False,"NO
Adult hereditary cancer testing (BRCA1/2) is contextually inconsistent and inappropriate when ordered for a 6-year-old whose indication is global developmental delay, a pediatric neurodevelopmental concern.",False,False,False
Case19087,BRCA1/2,False,"NO
Ordering BRCA1/2 testing for a 70-year-old whose indication is a complex neurodevelopmental disorder and autism is contextually inconsistent because BRCA testing addresses hereditary cancer risk, not neurodevelopmental diagnoses.",False,False,False
Case4365,BRCA1/2,False,"NO
Ordering BRCA1/2 testing for a 0-year-old being evaluated for intellectual disability is contextually inconsistent because BRCA1/2 are adult-onset cancer susceptibility genes and do not belong in a pediatric neurodevelopmental workup.",False,False,False
Case11810,BRCA1/2,True,"An 8-year-old patient was referred by a developmental pediatrician for BRCA1 and BRCA2 testing to assess familial predisposition to exocrine pancreatic cancer given a reported father with male breast cancer; prior fluorescent in situ hybridization testing was nondiagnostic and pre-test counseling was discussed with a genetic specialist, with coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",True,True,True
Case16246,BRCA1/2,True,"The patient is a 35-year-old woman with a personal history of breast cancer who meets criteria for hereditary testing because her diagnosis occurred before age 50, and she is being referred by her gynecologist for BRCA1 and BRCA2 testing with coverage through UHC; she reports a family history notable for an uncle with pancreatic cancer, prior karyotype testing was performed and was nondiagnostic, and no pre-test genetic counseling has been conducted.",True,True,True
Case2007,BRCA1/2,True,"An 18-year-old patient with metastatic breast cancer was referred by a family medicine physician for BRCA1 and BRCA2 testing because of a family history notable for the patient's mother having breast cancer at age 50 or younger, chromosomal microarray (CMA) was previously performed and was nondiagnostic, and no other prior genetic testing information is available; the patient completed pre-test counseling and will return for post-test counseling, and testing will be billed through BCBS_FEP.",True,True,True
Case19334,BRCA1/2,False,"The patient is a 5-year-old child with a reported personal history of exocrine pancreatic cancer who is being considered for BRCA1 and BRCA2 testing at the request of the general pediatrician, prior Fragile X testing was nondiagnostic, the child's father has a history of metastatic prostate cancer, and the family declined genetic counseling with testing to be submitted to Cigna for coverage.",True,False,True
Case15570,BRCA1/2,True,"The patient is a 15-year-old being followed by a general pediatrician for Hirschsprung disease and the clinician has requested BRCA1 and BRCA2 testing despite the pediatric gastrointestinal indication. Prior karyotype testing was nondiagnostic and the family history is notable for a mother with bipolar disorder, with no other cancer history documented. There is no documentation of pre-test genetic counseling and the test was ordered with coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",True,True,True
Case6478,BRCA1/2,True,"A 52-year-old man with metastatic prostate cancer is being referred by his general practitioner for germline BRCA1 and BRCA2 testing because of a family history notable for a father with pancreatic cancer; he has had no prior genetic testing, pre-test genetic counseling was not completed, and testing is being pursued with coverage through UHC to inform therapeutic options and cascade testing for at-risk relatives with plans for post-test counseling and oncology follow-up once results are available.",True,True,True
Case3677,BRCA1/2,True,"She is a 46-year-old woman with a personal history of breast cancer who is undergoing BRCA1/2 testing because of a close relative with pancreatic cancer and multiple other primary solid tumors on the same side of the family; prior chromosomal microarray (CMA) testing was nondiagnostic. The patient was referred by a nurse practitioner and completed pre-test genetic counseling with plans for post-test follow-up, and testing will be billed to UHC. Her family history is notable for a mother with pancreatic cancer and at least two additional affected relatives on the maternal side.",True,True,True
Case3581,BRCA1/2,True,"The patient is a 69-year-old adult for whom BRCA1 and BRCA2 testing has been ordered by the cardiologist to evaluate a history of significant hearing or visual impairment that was diagnosed by age 18. Prior fluorescence in situ hybridization testing was nondiagnostic, and the family history is notable for a sibling who experienced a brief resolved unexplained event characterized by altered responsiveness, cyanosis, pallor, and irregular breathing. No pre-test genetic counseling has been conducted and testing is being pursued with coverage through Cigna.",True,True,True
Case9206,BRCA1/2,False,"NO
BRCA1/2 testing in a 6-week-old infant presenting with hypotonia is unrealistic because BRCA testing is for adult-onset cancer susceptibility and should not be used to evaluate an infant neurodevelopmental presentation.",False,False,False
Case16146,BRCA1/2,True,"The patient is an 8-year-old referred by an obstetrician for BRCA1 and BRCA2 testing in the setting of multiple congenital anomalies that are not specific to a well-delineated genetic syndrome. Family history is notable for a maternal aunt with ovarian, fallopian tube, or peritoneal carcinoma, and prior fluorescence in situ hybridization testing was nondiagnostic. There is no documentation of pre-test genetic counseling and insurance coverage is through Cigna. Because BRCA-related cancer risk management is generally relevant in adulthood, the ordering team should ensure comprehensive counseling and consider the appropriateness of testing versus deferral until the patient is older.",True,True,True
Case6109,BRCA1/2,False,"NO
This scenario is unrealistic because a 40-year-old adult is being managed by a developmental pediatrician, and adult patients should not be managed by pediatric providers in this context.",False,False,False
Case18958,BRCA1/2,False,"NO
This is unrealistic because a 3-year-old cannot plausibly have a personal history of breast cancer, so BRCA1/2 hereditary cancer testing is inappropriate in this clinical context.",False,False,False
Case364,BRCA1/2,True,"The 15-year-old patient was referred by the primary care physician for BRCA1 and BRCA2 testing because they have a personal history of a primary solid tumor and report that a close blood relative was diagnosed with a primary solid tumor before age 40. Prior chromosomal microarray (CMA) testing was nondiagnostic, the patient has completed multiple sessions of pre-test genetic counseling with plans for post-test follow-up, and the family history also includes a mother with long QT syndrome. Testing will be pursued with coverage through BCBS_FEP.",True,True,True
Case15202,BRCA1/2,True,"The patient is a 65-year-old woman with a history of malignant phyllodes tumors of the breast who was referred by her gynecologist for BRCA1 and BRCA2 testing to evaluate possible hereditary breast and ovarian cancer risk, and she reports a sister with a persistent and severe immunologic or hematologic disorder in the family; Fragile X testing was previously performed and was nondiagnostic, pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and she has coverage through BCBS_FEP.",True,True,True
Case17849,BRCA1/2,False,"NO
BRCA1/2 testing and an indication of multiple primary breast cancers are not realistic for a 2-year-old, and the scenario improperly mixes pediatric neurodevelopmental family history with adult hereditary cancer testing.",False,False,False
Case18257,BRCA1/2,True,"The 64-year-old patient has a history of breast cancer diagnosed at age 50 or younger and is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic, family history is notable for a sibling with short stature, the test was ordered by the patient's general practitioner, there is no documentation of prior genetic counseling, and coverage is through Cigna.",True,True,True
Case7079,BRCA1/2,False,"NO
This case is unrealistic because BRCA1/2 testing is an adult-onset hereditary cancer evaluation and is contextually inconsistent with a 4-year-old presenting for a pediatric cardiac event together with a family history of global developmental delay.",False,False,False
Case6342,BRCA1/2,True,"Fifteen-year-old female with a personal history of early-onset breast cancer presented for hereditary cancer evaluation and BRCA1 and BRCA2 testing after referral from an oncologist and reports a mother who was diagnosed with breast cancer before age 50 and a sibling with bipolar disorder; Fragile X testing was previously performed and was nondiagnostic. She has seen a genetic counselor multiple times and will proceed with BRCA1/2 testing with coverage through Cigna, with plans for post-test counseling and coordination of pediatric oncology and surgical teams as indicated.",True,True,True
Case12792,BRCA1/2,True,"A 12-year-old was referred by a family medicine physician for BRCA1/2 testing in the setting of congenital choanal atresia and a reported growth abnormality in the mother. Prior fluorescent in situ hybridization (FISH) testing was nondiagnostic. Pre-test genetic counseling has been completed and post-test follow-up is planned, and testing will be billed through BCBS_FEP.",True,True,True
Case12175,BRCA1/2,False,"NO
This case is unrealistic because a 58-year-old adult would not be managed or have genetic testing ordered by a neonatologist.",False,False,False
Case14226,BRCA1/2,True,"A 55-year-old patient is being evaluated by oncology for germline BRCA1 and BRCA2 (BRCA1/2) testing because they have a personal history of a primary solid tumor other than basal or squamous cell skin cancer and risk assessment using Tyrer-Cuzick, BRCAPro, or Penn II calculators demonstrates a 2.5% or greater likelihood of a BRCA pathogenic variant; the patient has not undergone prior genetic testing and no pre-test genetic counseling was completed, and family history is notable for a mother with a persistent, severe hematologic or immunologic disorder, with testing being pursued with coverage through Cigna and results to be reviewed by the oncology team to inform management.",True,True,True
Case12275,BRCA1/2,False,"The patient is a 17-year-old referred by the cardiologist for evaluation of multiple congenital anomalies, and BRCA1/2 testing is being requested as part of the diagnostic workup; no prior genetic testing has been performed. Family history is notable for a sibling with autism spectrum disorder. Pre-test counseling was completed with a genetic specialist and plans for post-test follow-up are in place. The patient has coverage through UHC.",True,True,False
Case8538,BRCA1/2,False,"NO
BRCA1/2 testing on a fetus at 26 weeks gestation is inappropriate because adult-onset cancer susceptibility testing is not performed prenatally, and the prenatal record should not list postnatal neurodevelopmental diagnoses such as global developmental delay.",False,False,False
Case8572,BRCA1/2,False,"NO
BRCA1/2 testing for an 8-year-old evaluated for autism spectrum disorder is unrealistic because adult hereditary cancer testing should not be performed in the context of a pediatric neurodevelopmental indication.",False,False,False
Case14349,BRCA1/2,False,"NO
Meconium ileus is a neonatal-only presentation and thus is not a realistic current clinical indication for an 18-year-old.",False,False,False
Case964,BRCA1/2,False,"NO
The scenario is unrealistic because the stated indication is a pediatric-only label—intellectual disability diagnosed by age 18—which is not an appropriate current genetic testing indication for a 59-year-old adult.",False,False,False
Case19696,BRCA1/2,False,"The patient is a 9-year-old who was referred by neurology for genetic evaluation with planned BRCA1 and BRCA2 testing in the setting of a significant abnormality involving at least one organ system. Prior chromosomal microarray (CMA) testing was nondiagnostic, the family history is notable for a father with metastatic prostate cancer, pre-test counseling was completed with a genetic counselor on multiple occasions, and testing will be submitted with coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",False,True,True
Case19887,BRCA1/2,False,"NO
BRCA1/2 testing for a 21-year-old whose evaluation centers on congenital coloboma with a family history of hypotonia/hypertonia in infancy mixes adult hereditary cancer testing with pediatric neurodevelopmental indications and is contextually inconsistent.",False,False,False
Case10493,BRCA1/2,True,"An infant six weeks of age was referred by cardiology for genetic evaluation of multiple congenital anomalies affecting different organ systems, and the family reports that the mother has a congenital anomaly; Fragile X testing was previously performed and was nondiagnostic. The ordering cardiologist has requested BRCA1 and BRCA2 testing for the infant, there is no documentation of prior genetic counseling, and the family has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",True,True,True
Case2659,BRCA1/2,False,"NO
A 1-week-old infant cannot plausibly have been diagnosed with breast cancer under age 45, making the stated indication inconsistent with the patient’s age.",False,False,False
Case5303,BRCA1/2,True,"The 37-year-old patient was referred by neurology for BRCA1 and BRCA2 testing in the setting of a major abnormality affecting at least one organ system and a family history notable for a brother who died suddenly and unexpectedly before age 35; no prior genetic testing has been performed and no pre-test genetic counseling was conducted, and the patient has coverage through UHC.",True,True,True
Case19335,BRCA1/2,False,"NO
BRCA1/2 testing is for adult-onset cancer susceptibility and is inappropriate and unrealistic for a neonate being evaluated for multiple congenital anomalies with a family history of developmental regression.",False,False,False
Case14847,BRCA1/2,False,"NO
A neonatologist managing a 9-year-old child is unrealistic because neonatology is limited to newborns, creating an age–provider mismatch.",False,False,False
Case4765,BRCA1/2,False,"NO
Ordering BRCA1/2 testing for a seven-year-old being evaluated for persistent seizures is contextually inconsistent because BRCA testing assesses adult-onset cancer susceptibility and should not be part of a pediatric neurologic workup.",False,False,False
Case2666,BRCA1/2,True,"A 21-year-old woman with a major congenital cardiac anomaly is undergoing BRCA1/2 testing at the request of her obstetrician, and prior fluorescence in situ hybridization (FISH) testing was nondiagnostic; she reports a father with metastatic prostate cancer prompting consideration of hereditary cancer evaluation, pre-test counseling was completed with a genetic specialist and plans for post-test follow-up are in place, and she has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",True,True,True
Case14294,BRCA1/2,False,"NO
Adult hereditary cancer testing such as BRCA1/2 is inconsistent with a pediatric neurologic evaluation for hyperammonemia and suspected early-onset epileptic encephalopathy in a 13-year-old.",False,False,False
Case18716,BRCA1/2,False,"NO
A 58-year-old adult being managed by a neonatologist is not realistic because neonatologists care for neonates rather than adult patients.",False,False,False
Case502,CMA_developmental_disorder,False,"NO
The indication describes a fetal prenatal concern (fetal hydrops) but the patient age is 42 years, creating an inconsistent prenatal/age mismatch.",False,False,False
Case3592,CMA_developmental_disorder,True,"The patient is a neonate evaluated by a developmental pediatrician for unexplained epileptic encephalopathy with neonatal onset and no prior epilepsy multigene panel testing; chromosomal microarray (CMA) testing for developmental disorders is being requested. A prior chromosomal microarray was nondiagnostic. There is a family history of an older sibling with unexplained developmental regression unrelated to autism or epilepsy. Pre-test counseling was discussed with a genetic specialist and post-test follow-up is planned, and testing is being submitted with coverage through Cigna.",True,True,True
Case17595,CMA_developmental_disorder,True,"A 3-year-old child with significant hearing and visual impairment diagnosed by 18 years of age is being evaluated with chromosomal microarray (CMA) testing to assess for genomic causes of early-onset sensory impairment and associated developmental risk, and the test was ordered by a gynecologist; there is no prior genetic testing information, family history is notable for an uncle who had moderate to profound intellectual disability diagnosed by age 18, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through BCBS_FEP.",True,True,True
Case17090,CMA_tumor,False,"At 15 weeks' gestation the pregnancy was referred by a medical geneticist for tumor chromosomal microarray testing with a chromosomal microarray (CMA) to evaluate a prenatal imaging concern for a possible fetal primary solid tumor and to assess for chromosomal alterations in the setting of a family history notable for the patient's father having had breast cancer. No prior genetic testing information is available, pre-test counseling was completed and post-test counseling is planned, and testing will be billed through UHC.",True,False,False
Case10619,CMA,False,"A 7-year-old child was referred by a pediatric neurologist for genetic evaluation related to exocrine pancreatic cancer, and chromosomal microarray (CMA) testing is being requested to assess for copy number variants that might contribute to the clinical picture; the mother has a history of short stature suggestive of a familial growth abnormality, there is no prior genetic testing reported, and no pre-test genetic counseling has been conducted, with coverage through Cigna and plans for the ordering neurologist to review results and coordinate any necessary follow-up.",True,True,False
Case1020,CMA,False,"NO
The scenario is unrealistic because “multiple congenital abnormalities” is a pediatric-only indication and is not an appropriate current clinical indication for a 37-year-old adult.",False,False,False
Case5834,CMA_developmental_disorder,True,The patient is 67 years old and is under the care of neurology for a lifelong history of severe intellectual disability diagnosed by age 18 and is being referred for chromosomal microarray (CMA) testing to evaluate a genomic etiology for the developmental disorder. No prior genetic testing has been performed. Pre-test counseling has been completed with a genetic counselor on multiple occasions and plans for post-test follow-up were discussed. The family history is notable for the patient's mother having had ovarian cancer and testing is being requested with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).,True,True,True
Case16806,CMA_developmental_disorder,False,"NO
The indication of ""multiple congenital anomalies"" is a pediatric-only label and is not appropriate as a current indication for an adult patient (18 years), so the case is unrealistic.",False,False,False
Case15820,CMA_developmental_disorder,True,"The patient is a 31-year-old adult followed by neurology for developmental delay and intellectual disability without a suspected specific syndrome, and chromosomal microarray (CMA) has been ordered to evaluate for underlying copy number variants; no prior genetic testing has been reported, and the patient has completed multiple pre-test counseling sessions with a genetic counselor with plans for post-test follow-up, with insurance coverage through Cigna, and a pertinent family history of a mother who was diagnosed with breast cancer before age 50.",True,True,True
Case17929,CMA_tumor,True,"Referred by a neurologist, a 7-year-old child covered by UHC is being evaluated for a major abnormality affecting at least one organ system and tumor chromosomal microarray (CMA) testing has been requested to assess for genomic imbalance after prior karyotype testing was nondiagnostic, the family history is notable for a known BRCA1/2 pathogenic variant identified in the mother and a maternal aunt, and the child has had multiple pretest counseling sessions with a genetic counselor with plans for post-test follow-up with neurology and genetics.",True,True,True
Case2487,CMA_developmental_disorder,False,"NO
The case is unrealistic because a 30-year-old adult is listed with a pediatric-only indication of multiple congenital anomalies and is being managed by a developmental pediatrician, violating the age–indication and age–provider rules.",False,False,False
Case16495,CMA_developmental_disorder,False,"At 18 weeks' gestation the patient was referred by a neonatologist for prenatal evaluation with chromosomal microarray (CMA) to assess risk for possible postnatal cardiac channelopathy or structural heart disease given a family history of an inborn error of metabolism in an affected sibling and reports of a high‑risk brief resolved unexplained event with a significantly abnormal electrocardiogram in the family, a prior CMA was nondiagnostic, genetic counseling was declined, and testing is being pursued with coverage through UHC.",False,True,True
Case17196,CMA,True,"The patient is a 63-year-old referred by the oncologist for chromosomal microarray (CMA) testing to evaluate a longstanding neuropsychiatric presentation with features suggestive of bipolar disorder, schizophrenia, or obsessive-compulsive disorder. Previous karyotype testing was nondiagnostic. The family history is notable for a sibling who had significant hearing or visual impairment diagnosed by age 18. No pre-test genetic counseling has been conducted and the test is being requested with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS FEP).",True,True,True
Case11855,CMA_developmental_disorder,True,"The patient is a 14-year-old being evaluated by a developmental pediatrician for a congenital anomaly affecting a single organ system with concern for an underlying genetic etiology, and chromosomal microarray (CMA) is being ordered to assess for copy number variants associated with developmental disorders; Fragile X testing was previously performed and was nondiagnostic. There is a family history notable for a maternal aunt with triple-negative breast cancer, which was discussed as part of the risk assessment during pre-test counseling. Pre-test counseling was completed with a genetic specialist and plans for post-test follow-up were made, and testing will be pursued with coverage through UHC.",True,True,True
Case12834,CMA_tumor,True,"The patient is a 16-year-old referred by a developmental pediatrician for evaluation of a complex neurodevelopmental disorder affecting at least one organ system, and chromosomal microarray (CMA) testing has been ordered although the requisition specifies a tumor-type rather than a germline assay; prior Fragile X testing was nondiagnostic. There is a family history notable for a maternal uncle with a movement disorder described as dystonia and ataxia, genetic counseling is not documented in the record, and testing will be billed through Cigna.",True,True,True
Case8149,CMA_developmental_disorder,False,"NO
The case is inconsistent because the indication describes fetal structural anomalies yet the patient is an 18-year-old, so a prenatal/fetal testing context is not appropriate.",False,False,False
Case10075,CMA_developmental_disorder,True,"A four-week-old infant was seen by a developmental pediatrician for meconium ileus and consideration of chromosomal microarray (CMA) testing to evaluate for an underlying chromosomal or genetic etiology. Prior chromosomal microarray testing was nondiagnostic and there is a family history of an inborn error of metabolism in a sibling, raising concern for a heritable disorder. Pre-test counseling was completed with a genetic specialist and arrangements for post-test follow-up were discussed, and testing will be pursued with coverage through BCBS_FEP.",True,True,True
Case2783,CMA,False,"A 68-year-old with a history of choanal atresia is being evaluated by the primary care physician and referred for chromosomal microarray (CMA) testing to assess for an underlying genomic etiology given the congenital airway anomaly and a reported sibling with epileptic encephalopathy with onset before three years of age; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, the patient declined genetic counseling, and testing will be pursued with coverage through Cigna.",False,True,True
Case9773,CMA,True,"The two-year-old is undergoing evaluation for severe intellectual disability with chromosomal microarray (CMA) ordered to assess for genomic copy number changes; there is no prior genetic testing on record. The study was ordered by the child's oncologist given concern for an underlying genetic etiology and there is a family history of a maternal aunt with a persistent and severe immunologic disorder. The family has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP), and they completed pre-test genetic counseling with plans to return for post-test counseling after results are available.",True,True,True
Case10170,CMA,False,"NO
The clinical indication specifies invasive prenatal testing yet the patient is an 8-year-old child, so prenatal/fetal testing is inconsistent with the patient's age.",False,False,False

Summary,,,,,,
Total cases,200,,,,,
All 3 sets realistic,116,,,,,
All 3 sets realistic percentage,58.0%,,,,,
